siRNA SARS-CoV-2 Protein Interaction Study Reveals Key Proliferation Pathways, Possible Drug Targets Premium The study compared SARS-CoV-2 to SARS-CoV-1 and MERS to find viral commonalities, and combined the analyses with real-world clinical data to suggest treatments. Biotech Startup Korro Bio Uses Temporary Gene Editing Technology to Create Therapeutics Premium The company's platform is based on nucleotide deamination, a process that occurs naturally in cells and doesn't create a permanent edit in the genome. Cowen Initiates Coverage of Horizon Discovery at Outperform The investment bank began coverage with an Outperform rating, noting that Horizon's recent acquisition of Dharmacon is highly complementary and synergistic. Startup Persomics Aims to Launch Mini RNAi Screening Tech by Year-End Premium With optimization work currently being done with beta testers, the company is negotiating with companies to provide their siRNA library content on its plates. IP Update: Recent Patents Awarded to Alnylam, Tekmira, Polyplus, and More Premium Title: RNA Interference Modulators of Hedgehog Signaling and Uses Thereof Patent Number: 8,802,639 Filed: March 24, 2005 Jun 26, 2014 InteRNA, Collaborators Publish Details of siRNA, microRNA Delivery Technology Premium Jan 9, 2014 Dicerna Poised to Become Second RNAi Drug Firm to Complete IPO Premium Jan 7, 2014 Horizon, AstraZeneca Collaborate on Genotypes for Synthetic Lethality Dec 12, 2013 Life Tech Allows Release of Full siRNA Sequence Data from NIH RNAi Screens Premium Nov 25, 2013 RNAi Screen Finds Regulators of Parkin, Suggests Possible Therapeutic Targets Oct 31, 2013 Washington University Team Develops Molecules Combining siRNA, microRNA Effects Premium Oct 24, 2013 People in the News: Vincent Calvez, Diane Descamps, Jacques Reynes, Mark Wainberg, Brett Begemann, Gregory Weaver Premium Oct 3, 2013 Merck Reorganization Raises Questions over Company's RNAi Programs Premium Jun 20, 2013 Suzhou Ribo Life Sciences Takes License to Life Tech siRNA Drug-delivery Technology Premium Oct 18, 2012 Working to Stay Afloat, Marina Aims to Avoid Becoming Latest RNAi Drug Disappearing Act Premium Oct 2, 2012 Falcon Genomics Showcases Cancer Biochip in Breast Cancer Studies; Plans Next-Gen System Premium Apr 12, 2012 NIH Awards $1.3M in siRNA Delivery-Related Grants Last Month Premium Mar 29, 2012 New Products: Takara Bio Europe's Xfect siRNA Transfection Reagent; Exiqon's miRcury LNA microRNA Array Premium Mar 22, 2012 Metabolic Screen Leads to Gene Contributing to Prostate Cancer Survival Mar 1, 2012 Q&A: MIT's Paula Hammond on siRNA Delivery Via All-RNA Microsponges Premium Jan 26, 2012 New Products: Qiagen's FlexiPlate siRNA Libraries Premium Dec 8, 2011 As RNAi Efforts Advance, Merck Aims to Move siRNA Drug into the Clinic in 'One to Two Years' Premium Nov 17, 2011 Leonardo Receives Second Half of $2.5M Grant Premium Nov 10, 2011 Arrowhead Releases White Paper on Newly Acquired siRNA Delivery Technology Premium Nov 10, 2011 Access Inks Delivery Technology-Evaluation Deal with Undisclosed Pharma Premium Load More Breaking News Sequencing Study Uncovers MERS-Related Coronavirus in Swiss Bats Angstrom Bio Raises $3M in Private Financing Eagle Biosciences, Genetic Analysis Ink Distribution Agreement for Gut Microbiota Test Centogene Q1 Revenues Grow More Than Fivefold Driven by COVID-19 Testing Epizyme Partnering With Quest Diagnostics for Lymphoma Mutation Testing Enzo Biochem, CLX Health Partner to Support COVID-19 Testing for International Travel The Scan CDC Calls Delta "Variant of Concern" CNN reports the US Centers for Disease Control and Prevention now considers the Delta variant of SARS-CoV-2 to be a "variant of concern." From FDA to Venture Capital Former FDA Commissioner Stephen Hahn is taking a position at a venture capital firm, leading some ethicists to raise eyebrows, according to the Washington Post. Consent Questions Nature News writes that there are questions whether informed consent was obtained for some submissions to a database of Y-chromosome profiles. Cell Studies on Multimodal Single-Cell Analysis, Coronaviruses in Bats, Urban Microbiomes In Cell this week: approach to analyze multimodal single-cell genomic data, analysis of bat coronaviruses, and more.